Inactive Instrument

Analyst Reco. Alteryx, Inc. Xetra

Equities

3AI

US02156B1035

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Piper Sandler Adjusts Price Target on Alteryx to $48.25 From $50, Maintains Neutral Rating	01-02	MT
Citigroup Downgrades Alteryx to Neutral From Buy, Price Target is $48.25	12-19	MT
Rosenblatt Downgrades Alteryx to Neutral From Buy	12-19	MT
Truist Securities Downgrades Alteryx to Hold From Buy, Adjusts Price Target to $48.25 From $45	12-18	MT
Needham Adjusts Price Target on Alteryx to $56 From $42, Keeps Buy Rating	12-15	MT
Piper Sandler Upgrades Alteryx to Neutral From Underweight, Raises Price Target to $50 From $32	12-15	MT
Oppenheimer Adjusts Alteryx Price Target to $50 From $55, Maintains Outperform Rating	11-07	MT
Piper Sandler Adjusts Price Target on Alteryx to $32 From $30, Maintains Underweight Rating	11-07	MT
Piper Sandler Downgrades Alteryx to Underweight From Neutral, Price Target is $30	23-10-23	MT
Morgan Stanley Upgrades Alteryx to Overweight From Equalweight, Says Valuation 'Undervalues' Growth, Profit Potential; Price Target Kept at $54	23-09-18	MT
Needham Raises Price Target on Alteryx to $42 From $35, Maintains Buy Rating	23-09-07	MT
William Blair Reinstates Coverage on Alteryx Market Perform Rating	23-08-31	MT
Citigroup Adjusts Price Target on Alteryx to $73 From $70, Maintains Buy Rating	23-08-08	MT
Rosenblatt Adjusts Alteryx's Price Target to $60 From $75, Keeps Buy Rating	23-08-08	MT
Morgan Stanley Trims Price Target on Alteryx to $54 From $59, Maintains Equalweight Rating	23-08-08	MT
JMP Securities Cuts Price Target on Alteryx to $60 From $95, Maintains Market Market Outperform Rating	23-08-08	MT
Needham Cuts Price Target on Alteryx to $35 From $55, Maintains Buy Rating	23-08-08	MT
Loop Capital Downgrades Alteryx to Hold From Buy, Cuts Price Target to $30 From $65	23-08-08	MT
Oppenheimer Adjusts Alteryx Price Target to $55 From $65, Maintains Outperform Rating	23-08-08	MT
Wedbush Cuts Alteryx's Price Target to $45 From $60 After Weaker-Than-Expected Q2 Results, Keeps Neutral Rating	23-08-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Alteryx, Inc. Xetra

Equities

3AI

US02156B1035

Analyst Reco.

Filters